April 28th 2025
Limiting the number of fresh donor oocytes fertilized can reduce excess embryo creation while maintaining high live birth rates.
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations
View More
Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment
View More
Radiation-Sparing Managements for Cervical Cancer: A Developing Countries Perspective
September 22nd 2011Cervical cancer is the seventh most frequent cancer worldwide but more than 80% of cases occur in developing countries. Till date, radiation therapy with external beam and brachytherapy remains as the core treatment for most stages of cervical cancer.
Read More
Epigenetics of cervical cancer. An overview and therapeutic perspectives
September 22nd 2011Cervical cancer remains one of the greatest killers of women worldwide. It is difficult to foresee a dramatic increase in cure rate even with the most optimal combination of cytotoxic drugs, surgery, and radiation; therefore, testing of molecular targeted therapies against this malignancy is highly desirable.
Read More
Uterine Fibroids are classified by their location (see figure), which effects the symptoms they may cause and how they can be treated. Fibroids that are inside the cavity of the uterus (Submucous myomas) will often cause bleeding between periods and often cause severe cramping. Fortunately, these fibroids can usually be easily removed by a method called “hysteroscopic resection,” which can be done through the cervix without the need for an incision.
Read More
STI Reinfection Rates Reduced by Expedited Partner Therapy
September 19th 2011When chlamydia or gonorrhea is diagnosed in female patients, obstetricians and gynecologists should also prescribe antibiotics for the male partners. This recommendation comes from The American College of Obstetricians and Gynecologists in efforts to reduce the high reinfection rates associated with these sexually transmitted infections (STIs).
Read More
Ovarian Hyperstimulation Syndrome and Prophylactic Human Embryo Cryopreservation
September 14th 2011To review utilisation of elective embryo cryopreservation in the expectant management of patients at risk for developing ovarian hyperstimulation syndrome (OHSS), and report on reproductive outcome following transfer of thawed embryos.
Read More
Accurate diagnosis of uterine fibroids is essential in deciding if treatment is necessary, and planning appropriate treatment.n While a physical exam may suggest fibroids, other conditions such as ovarian cysts or adenomyosis may be mistaken for fibroids. For this reason, I routinely do an ultrasound examination at the time of the first visit when a woman has symptoms of abnormal bleeding or cramping, or if I feel an abnormality on examination.
Read More
Mesothelin Antibodies May Be Key to Early Detection of Ovarian Cancer
August 30th 2011Compared to healthy women, the researchers found significantly higher serum mesothelin antigen levels in women with ovarian cancer, benign conditions, and unexplained infertility. Luborsky and colleagues further noted that mesothelin antibodies had a higher affinity in the infertility groups, especially premature ovarian failure and ovulatory dysfunction, than that in the healthy, benign, or ovarian cancer groups. Specifically, they found significantly higher positive sera in women with premature ovarian failure and ovulatory dysfunction as compared to normal sera.
Read More
Laparoscopic Myomectomy uses a small telescope placed through the belly button along with several small instruments to remove fibroids from the uterus. The technique of actually removing the fibroid from the uterus is similar to that of an abdominal myomectomy except we use small instruments placed through the abdominal wall. Once the fibroid is freed from the uterus it needs to be removed from the abdomen. In order to remove a large fibroid from a small incision we use an instrument called a morcellator, to cut it into pieces small enough to be removed through the small incisions.
Read More
Predictive Value of Yolk Sac in Early Pregnancy by Ultra-Sonography
August 9th 2011Presented by Dr. Narayan M. Patel Prof. Emeritus, ob/gyn.muni.medical collage, Postal address: - Mahalaxmi institute of medical teaching3, shantiniketan park, Nr. S. P. Colony Ahmedabad-380014 Gujarat state (INDIA) Phone: - (079) 27682572 Email: narayanpatel1932@yahoo.com
Read More